nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—PTGS1—Sulfasalazine—ankylosing spondylitis	0.226	0.274	CbGbCtD
Trabectedin—CYP2C19—Prednisone—ankylosing spondylitis	0.0876	0.106	CbGbCtD
Trabectedin—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0873	0.106	CbGbCtD
Trabectedin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0699	0.0847	CbGbCtD
Trabectedin—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0547	0.0663	CbGbCtD
Trabectedin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.053	0.0642	CbGbCtD
Trabectedin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0455	0.0551	CbGbCtD
Trabectedin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0455	0.0551	CbGbCtD
Trabectedin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0449	0.0544	CbGbCtD
Trabectedin—CYP3A4—Prednisone—ankylosing spondylitis	0.0424	0.0513	CbGbCtD
Trabectedin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0416	0.0504	CbGbCtD
Trabectedin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0264	0.032	CbGbCtD
Trabectedin—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.00138	0.0079	CcSEcCtD
Trabectedin—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.00138	0.00788	CcSEcCtD
Trabectedin—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.00133	0.00759	CcSEcCtD
Trabectedin—Necrosis—Methotrexate—ankylosing spondylitis	0.0013	0.00747	CcSEcCtD
Trabectedin—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	0.00129	0.00739	CcSEcCtD
Trabectedin—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.00125	0.00717	CcSEcCtD
Trabectedin—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.00125	0.00717	CcSEcCtD
Trabectedin—Extravasation—Methotrexate—ankylosing spondylitis	0.00117	0.00672	CcSEcCtD
Trabectedin—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.00113	0.00645	CcSEcCtD
Trabectedin—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.00109	0.00624	CcSEcCtD
Trabectedin—Sepsis—Prednisone—ankylosing spondylitis	0.00106	0.00609	CcSEcCtD
Trabectedin—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.00102	0.00586	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.000991	0.00567	CcSEcCtD
Trabectedin—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00093	0.00532	CcSEcCtD
Trabectedin—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00093	0.00532	CcSEcCtD
Trabectedin—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000912	0.00522	CcSEcCtD
Trabectedin—Sepsis—Methotrexate—ankylosing spondylitis	0.000889	0.00509	CcSEcCtD
Trabectedin—Infestation—Methylprednisolone—ankylosing spondylitis	0.000866	0.00495	CcSEcCtD
Trabectedin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.000866	0.00495	CcSEcCtD
Trabectedin—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000851	0.00487	CcSEcCtD
Trabectedin—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000847	0.00485	CcSEcCtD
Trabectedin—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000827	0.00473	CcSEcCtD
Trabectedin—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00081	0.00463	CcSEcCtD
Trabectedin—Weight decreased—Dexamethasone—ankylosing spondylitis	0.000799	0.00457	CcSEcCtD
Trabectedin—Weight decreased—Betamethasone—ankylosing spondylitis	0.000799	0.00457	CcSEcCtD
Trabectedin—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.000785	0.00449	CcSEcCtD
Trabectedin—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.000783	0.00448	CcSEcCtD
Trabectedin—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000781	0.00447	CcSEcCtD
Trabectedin—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000779	0.00446	CcSEcCtD
Trabectedin—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000777	0.00445	CcSEcCtD
Trabectedin—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000764	0.00437	CcSEcCtD
Trabectedin—Neutropenia—Prednisone—ankylosing spondylitis	0.000719	0.00411	CcSEcCtD
Trabectedin—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00071	0.00407	CcSEcCtD
Trabectedin—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00071	0.00407	CcSEcCtD
Trabectedin—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000707	0.00404	CcSEcCtD
Trabectedin—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000707	0.00404	CcSEcCtD
Trabectedin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000705	0.00404	CcSEcCtD
Trabectedin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0007	0.00401	CcSEcCtD
Trabectedin—Weight decreased—Prednisone—ankylosing spondylitis	0.000696	0.00398	CcSEcCtD
Trabectedin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000681	0.0039	CcSEcCtD
Trabectedin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000676	0.00387	CcSEcCtD
Trabectedin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000664	0.0038	CcSEcCtD
Trabectedin—Syncope—Prednisolone—ankylosing spondylitis	0.000661	0.00378	CcSEcCtD
Trabectedin—Back pain—Triamcinolone—ankylosing spondylitis	0.000656	0.00375	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000648	0.00371	CcSEcCtD
Trabectedin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000641	0.00367	CcSEcCtD
Trabectedin—Angiopathy—Betamethasone—ankylosing spondylitis	0.000641	0.00367	CcSEcCtD
Trabectedin—Alopecia—Dexamethasone—ankylosing spondylitis	0.000624	0.00357	CcSEcCtD
Trabectedin—Alopecia—Betamethasone—ankylosing spondylitis	0.000624	0.00357	CcSEcCtD
Trabectedin—Haemoglobin—Prednisone—ankylosing spondylitis	0.000619	0.00354	CcSEcCtD
Trabectedin—Haemorrhage—Prednisone—ankylosing spondylitis	0.000615	0.00352	CcSEcCtD
Trabectedin—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00061	0.00349	CcSEcCtD
Trabectedin—Syncope—Triamcinolone—ankylosing spondylitis	0.000608	0.00348	CcSEcCtD
Trabectedin—Syncope—Methylprednisolone—ankylosing spondylitis	0.000607	0.00347	CcSEcCtD
Trabectedin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000605	0.00346	CcSEcCtD
Trabectedin—Oedema—Prednisolone—ankylosing spondylitis	0.000602	0.00344	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—ankylosing spondylitis	0.000601	0.00344	CcSEcCtD
Trabectedin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000596	0.00341	CcSEcCtD
Trabectedin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000595	0.0034	CcSEcCtD
Trabectedin—Shock—Prednisolone—ankylosing spondylitis	0.000592	0.00339	CcSEcCtD
Trabectedin—Cough—Triamcinolone—ankylosing spondylitis	0.000592	0.00339	CcSEcCtD
Trabectedin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000577	0.0033	CcSEcCtD
Trabectedin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000576	0.0033	CcSEcCtD
Trabectedin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000576	0.0033	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000573	0.00328	CcSEcCtD
Trabectedin—Infestation—Methotrexate—ankylosing spondylitis	0.000573	0.00328	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000572	0.00327	CcSEcCtD
Trabectedin—Flushing—Prednisone—ankylosing spondylitis	0.000571	0.00327	CcSEcCtD
Trabectedin—Stomatitis—Methotrexate—ankylosing spondylitis	0.000558	0.0032	CcSEcCtD
Trabectedin—Angiopathy—Prednisone—ankylosing spondylitis	0.000558	0.0032	CcSEcCtD
Trabectedin—Oedema—Triamcinolone—ankylosing spondylitis	0.000553	0.00317	CcSEcCtD
Trabectedin—Syncope—Dexamethasone—ankylosing spondylitis	0.000552	0.00316	CcSEcCtD
Trabectedin—Syncope—Betamethasone—ankylosing spondylitis	0.000552	0.00316	CcSEcCtD
Trabectedin—Infection—Triamcinolone—ankylosing spondylitis	0.00055	0.00315	CcSEcCtD
Trabectedin—Infection—Methylprednisolone—ankylosing spondylitis	0.000548	0.00314	CcSEcCtD
Trabectedin—Shock—Triamcinolone—ankylosing spondylitis	0.000544	0.00312	CcSEcCtD
Trabectedin—Insomnia—Prednisolone—ankylosing spondylitis	0.000544	0.00311	CcSEcCtD
Trabectedin—Alopecia—Prednisone—ankylosing spondylitis	0.000544	0.00311	CcSEcCtD
Trabectedin—Shock—Methylprednisolone—ankylosing spondylitis	0.000543	0.00311	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000542	0.0031	CcSEcCtD
Trabectedin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000541	0.0031	CcSEcCtD
Trabectedin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000541	0.00309	CcSEcCtD
Trabectedin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000541	0.00309	CcSEcCtD
Trabectedin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00054	0.00309	CcSEcCtD
Trabectedin—Mental disorder—Prednisone—ankylosing spondylitis	0.000539	0.00309	CcSEcCtD
Trabectedin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000536	0.00307	CcSEcCtD
Trabectedin—Malnutrition—Prednisone—ankylosing spondylitis	0.000536	0.00307	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000535	0.00306	CcSEcCtD
Trabectedin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000524	0.003	CcSEcCtD
Trabectedin—Myalgia—Betamethasone—ankylosing spondylitis	0.000524	0.003	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000517	0.00296	CcSEcCtD
Trabectedin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000516	0.00295	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000514	0.00294	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000504	0.00289	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000503	0.00288	CcSEcCtD
Trabectedin—Oedema—Dexamethasone—ankylosing spondylitis	0.000502	0.00287	CcSEcCtD
Trabectedin—Oedema—Betamethasone—ankylosing spondylitis	0.000502	0.00287	CcSEcCtD
Trabectedin—Insomnia—Triamcinolone—ankylosing spondylitis	0.0005	0.00286	CcSEcCtD
Trabectedin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000499	0.00286	CcSEcCtD
Trabectedin—Infection—Betamethasone—ankylosing spondylitis	0.000499	0.00285	CcSEcCtD
Trabectedin—Infection—Dexamethasone—ankylosing spondylitis	0.000499	0.00285	CcSEcCtD
Trabectedin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000497	0.00284	CcSEcCtD
Trabectedin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000496	0.00284	CcSEcCtD
Trabectedin—Anaemia—Prednisone—ankylosing spondylitis	0.000495	0.00283	CcSEcCtD
Trabectedin—Shock—Betamethasone—ankylosing spondylitis	0.000494	0.00283	CcSEcCtD
Trabectedin—Shock—Dexamethasone—ankylosing spondylitis	0.000494	0.00283	CcSEcCtD
Trabectedin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000493	0.00282	CcSEcCtD
Trabectedin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000492	0.00282	CcSEcCtD
Trabectedin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000492	0.00282	CcSEcCtD
Trabectedin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000492	0.00281	CcSEcCtD
Trabectedin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000492	0.00281	CcSEcCtD
Trabectedin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000487	0.00279	CcSEcCtD
Trabectedin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000486	0.00278	CcSEcCtD
Trabectedin—Syncope—Prednisone—ankylosing spondylitis	0.00048	0.00275	CcSEcCtD
Trabectedin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000479	0.00274	CcSEcCtD
Trabectedin—Anorexia—Betamethasone—ankylosing spondylitis	0.000479	0.00274	CcSEcCtD
Trabectedin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000477	0.00273	CcSEcCtD
Trabectedin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000476	0.00272	CcSEcCtD
Trabectedin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000471	0.00269	CcSEcCtD
Trabectedin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000469	0.00269	CcSEcCtD
Trabectedin—Hypotension—Betamethasone—ankylosing spondylitis	0.000469	0.00269	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000467	0.00267	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000464	0.00265	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000457	0.00262	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000457	0.00262	CcSEcCtD
Trabectedin—Arthralgia—Prednisone—ankylosing spondylitis	0.000456	0.00261	CcSEcCtD
Trabectedin—Myalgia—Prednisone—ankylosing spondylitis	0.000456	0.00261	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—ankylosing spondylitis	0.000454	0.0026	CcSEcCtD
Trabectedin—Insomnia—Betamethasone—ankylosing spondylitis	0.000454	0.0026	CcSEcCtD
Trabectedin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000454	0.0026	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000453	0.00259	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000451	0.00258	CcSEcCtD
Trabectedin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000451	0.00258	CcSEcCtD
Trabectedin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000451	0.00258	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000451	0.00258	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—ankylosing spondylitis	0.000448	0.00256	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000443	0.00254	CcSEcCtD
Trabectedin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000442	0.00253	CcSEcCtD
Trabectedin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000442	0.00253	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000438	0.00251	CcSEcCtD
Trabectedin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000437	0.0025	CcSEcCtD
Trabectedin—Oedema—Prednisone—ankylosing spondylitis	0.000437	0.0025	CcSEcCtD
Trabectedin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000436	0.0025	CcSEcCtD
Trabectedin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000436	0.0025	CcSEcCtD
Trabectedin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000436	0.0025	CcSEcCtD
Trabectedin—Infection—Prednisone—ankylosing spondylitis	0.000434	0.00249	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000433	0.00248	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000433	0.00248	CcSEcCtD
Trabectedin—Back pain—Methotrexate—ankylosing spondylitis	0.000433	0.00248	CcSEcCtD
Trabectedin—Fatigue—Betamethasone—ankylosing spondylitis	0.000433	0.00248	CcSEcCtD
Trabectedin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000433	0.00248	CcSEcCtD
Trabectedin—Shock—Prednisone—ankylosing spondylitis	0.00043	0.00246	CcSEcCtD
Trabectedin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000429	0.00245	CcSEcCtD
Trabectedin—Skin disorder—Prednisone—ankylosing spondylitis	0.000425	0.00243	CcSEcCtD
Trabectedin—Anorexia—Prednisone—ankylosing spondylitis	0.000417	0.00239	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—ankylosing spondylitis	0.000414	0.00237	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000411	0.00235	CcSEcCtD
Trabectedin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000411	0.00235	CcSEcCtD
Trabectedin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000408	0.00233	CcSEcCtD
Trabectedin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000407	0.00233	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000401	0.00229	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000398	0.00228	CcSEcCtD
Trabectedin—Dizziness—Prednisolone—ankylosing spondylitis	0.000398	0.00228	CcSEcCtD
Trabectedin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000397	0.00227	CcSEcCtD
Trabectedin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000397	0.00227	CcSEcCtD
Trabectedin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000397	0.00227	CcSEcCtD
Trabectedin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000397	0.00227	CcSEcCtD
Trabectedin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000397	0.00227	CcSEcCtD
Trabectedin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000396	0.00227	CcSEcCtD
Trabectedin—Insomnia—Prednisone—ankylosing spondylitis	0.000395	0.00226	CcSEcCtD
Trabectedin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000393	0.00225	CcSEcCtD
Trabectedin—Cough—Methotrexate—ankylosing spondylitis	0.000391	0.00224	CcSEcCtD
Trabectedin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000385	0.0022	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000381	0.00218	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—ankylosing spondylitis	0.000381	0.00218	CcSEcCtD
Trabectedin—Decreased appetite—Prednisone—ankylosing spondylitis	0.00038	0.00218	CcSEcCtD
Trabectedin—Rash—Prednisolone—ankylosing spondylitis	0.000379	0.00217	CcSEcCtD
Trabectedin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000379	0.00217	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000379	0.00217	CcSEcCtD
Trabectedin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000378	0.00216	CcSEcCtD
Trabectedin—Fatigue—Prednisone—ankylosing spondylitis	0.000377	0.00216	CcSEcCtD
Trabectedin—Headache—Prednisolone—ankylosing spondylitis	0.000377	0.00216	CcSEcCtD
Trabectedin—Constipation—Prednisone—ankylosing spondylitis	0.000374	0.00214	CcSEcCtD
Trabectedin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000366	0.00209	CcSEcCtD
Trabectedin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000365	0.00209	CcSEcCtD
Trabectedin—Infection—Methotrexate—ankylosing spondylitis	0.000363	0.00208	CcSEcCtD
Trabectedin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00036	0.00206	CcSEcCtD
Trabectedin—Asthenia—Betamethasone—ankylosing spondylitis	0.00036	0.00206	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000358	0.00205	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000358	0.00205	CcSEcCtD
Trabectedin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000358	0.00205	CcSEcCtD
Trabectedin—Nausea—Prednisolone—ankylosing spondylitis	0.000357	0.00205	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000355	0.00203	CcSEcCtD
Trabectedin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000352	0.00201	CcSEcCtD
Trabectedin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000351	0.00201	CcSEcCtD
Trabectedin—Rash—Triamcinolone—ankylosing spondylitis	0.000349	0.002	CcSEcCtD
Trabectedin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000349	0.00199	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—ankylosing spondylitis	0.000348	0.00199	CcSEcCtD
Trabectedin—Rash—Methylprednisolone—ankylosing spondylitis	0.000348	0.00199	CcSEcCtD
Trabectedin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000348	0.00199	CcSEcCtD
Trabectedin—Headache—Triamcinolone—ankylosing spondylitis	0.000347	0.00198	CcSEcCtD
Trabectedin—Headache—Methylprednisolone—ankylosing spondylitis	0.000346	0.00198	CcSEcCtD
Trabectedin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000346	0.00198	CcSEcCtD
Trabectedin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000346	0.00198	CcSEcCtD
Trabectedin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000344	0.00197	CcSEcCtD
Trabectedin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000344	0.00197	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—ankylosing spondylitis	0.000341	0.00195	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000333	0.00191	CcSEcCtD
Trabectedin—Dizziness—Betamethasone—ankylosing spondylitis	0.000332	0.0019	CcSEcCtD
Trabectedin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000332	0.0019	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—ankylosing spondylitis	0.000331	0.00189	CcSEcCtD
Trabectedin—Nausea—Triamcinolone—ankylosing spondylitis	0.000329	0.00188	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000328	0.00188	CcSEcCtD
Trabectedin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000328	0.00188	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000326	0.00186	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000322	0.00184	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000322	0.00184	CcSEcCtD
Trabectedin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000319	0.00183	CcSEcCtD
Trabectedin—Vomiting—Betamethasone—ankylosing spondylitis	0.000319	0.00183	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000318	0.00182	CcSEcCtD
Trabectedin—Rash—Dexamethasone—ankylosing spondylitis	0.000317	0.00181	CcSEcCtD
Trabectedin—Rash—Betamethasone—ankylosing spondylitis	0.000317	0.00181	CcSEcCtD
Trabectedin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000316	0.00181	CcSEcCtD
Trabectedin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000316	0.00181	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000315	0.00181	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—ankylosing spondylitis	0.000315	0.0018	CcSEcCtD
Trabectedin—Headache—Dexamethasone—ankylosing spondylitis	0.000315	0.0018	CcSEcCtD
Trabectedin—Headache—Betamethasone—ankylosing spondylitis	0.000315	0.0018	CcSEcCtD
Trabectedin—Asthenia—Prednisone—ankylosing spondylitis	0.000314	0.0018	CcSEcCtD
Trabectedin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000299	0.00171	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000299	0.00171	CcSEcCtD
Trabectedin—Nausea—Dexamethasone—ankylosing spondylitis	0.000298	0.00171	CcSEcCtD
Trabectedin—Nausea—Betamethasone—ankylosing spondylitis	0.000298	0.00171	CcSEcCtD
Trabectedin—Dizziness—Prednisone—ankylosing spondylitis	0.000289	0.00165	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000289	0.00165	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000289	0.00165	CcSEcCtD
Trabectedin—Vomiting—Prednisone—ankylosing spondylitis	0.000278	0.00159	CcSEcCtD
Trabectedin—Rash—Prednisone—ankylosing spondylitis	0.000276	0.00158	CcSEcCtD
Trabectedin—Dermatitis—Prednisone—ankylosing spondylitis	0.000275	0.00158	CcSEcCtD
Trabectedin—Headache—Prednisone—ankylosing spondylitis	0.000274	0.00157	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000269	0.00154	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—ankylosing spondylitis	0.000262	0.0015	CcSEcCtD
Trabectedin—Nausea—Prednisone—ankylosing spondylitis	0.00026	0.00149	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00025	0.00143	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—ankylosing spondylitis	0.000242	0.00138	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—ankylosing spondylitis	0.000232	0.00133	CcSEcCtD
Trabectedin—Rash—Methotrexate—ankylosing spondylitis	0.00023	0.00132	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00023	0.00132	CcSEcCtD
Trabectedin—Headache—Methotrexate—ankylosing spondylitis	0.000229	0.00131	CcSEcCtD
Trabectedin—Nausea—Methotrexate—ankylosing spondylitis	0.000217	0.00124	CcSEcCtD
